Source: Eur Respir J 2001; 18: 635-639
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Lehtimaki L., Kankaanranta H., Saarelainen S., Turjanmaa V., Moilanen E.. Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J 2001; 18: 635-639

Member's Comments

No comment yet.

Related content which might interest you: Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children Source: Eur Respir J 2002; 20: 630-634 Year: 2002 Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge Source: Eur Respir J 2006; 27: 1152-1159 Year: 2006 Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms Source: Eur Respir J 2002; 20: 841-845 Year: 2002 Increased nitric oxide production by neutrophils in bronchial asthma Source: Eur Respir J 2001; 17: 868-871 Year: 2001 Changes of exhaled nitric oxide during steroid treatment of childhood asthma Source: Eur Respir J 2002; 19: 1015-1019 Year: 2002 Are bronchial hyperresponsiveness and exhaled nitric oxide related in asthma? Effects of fluticasone Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 Exhaled nitric oxide in asthma Source: Eur Respir Monogr 2010; 49: 32-44 Year: 2010 Exhaled nitric oxide and lower airway involvement in persistent rhinitis Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 366s Year: 2007 The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012 The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma Source: Eur Respir J 2005; 25: 289-294 Year: 2005 Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004 Effect of systemic and extra-fine particle inhaled corticosteroids on corrected alveolar nitric oxide (CANO) in COPD Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 Onset of action of inhaled corticosteroids on bronchial and alveolar nitric oxide output Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020 The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 Domiciliary exhaled nitric oxide and eosinophilic airway inflammation in adults with asthma Source: Eur Respir J 2016; 48: 242-244 Year: 2016 Evaluation of exhaled nitric oxide and sputum eosinophils as markers of inflammation in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 176s Year: 2003 Effect of inhaled steroids and long-acting β2 agonists on exhaled nitric oxide (eNO) in asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 270s Year: 2004 Inhaled salbutamol significantly affects the bronchial production of nitric oxide in normal subjects Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Exhaled nitric oxide is a useful marker of airway hyperreactivity in patients with chronic cough Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005